Global Business in the Digital Age and Post-COVID-19
5th International Conference East China University of Science & Technology - University of San Francisco
Digital technology has profoundly reshaped global business. Not only has it accelerated the process of firm internationalization but also facilitated inter-firm cross-border cooperation. However, for the global top 100 digital multinationals, only 41% of their total assets are located overseas, compared with 65% for traditional multinationals, showing a considerable difference between these two groups. In terms of sales, 73% of digital multinationals' sales are overseas, compared with 64% for traditional multinationals. Furthermore, technological competition has intensified across national boundaries. However, the increasing geopolitical tensions and the rise of nationalism have led many countries to restrict the use of digital technology, thereby limiting the flow of information and cross-border business activities.
With the Covid-19 Pandemic and its impact on business digital transformation, companies face new opportunities and challenges in the global arena. How can they deal with the precarious changes and achieve sustainable international growth? What are the characteristics of effective business models in today’s global business environment? These issues will be extensively discussed during the 5th ECUST & USF International Conference to be held virtually on June 12-13, 2021 (North America Pacific Standard Time: June 11-12). The Conference will provide a platform to exchange views on various business challenges and solutions in today’s environment. During the two-day conference, there will be a variety of sessions/activities, including keynote speeches, academic and industry dialogues, an education leaders’ forum, regular and special paper sessions, etc. We sincerely welcome scholars, education leaders, industry executives, entrepreneurs, and policymakers to participate in our discussions.
Join us for another riveting CBSI hosted event. There is no denying that China has been a global leader in many areas over the past few decades. Perhaps one of its significant influences has arguably been China's ability to invest in developing economies, specifically direct investments to African nations, ranging from mining raw materials, infrastructure development, and market penetration. Finally, China's political motivation in Africa's development is undoubtedly achieving a more significant global influence. The purpose of this CBSI panel is to examine whether or not China's interests in Africa are legitimate particularity in the 21st century's ever-changing global economy and what the US should do in response, if anything.
The RCEP, China EU CAI and Canada
This upcoming event is designated to address the potential responses in Canadian policies to two recent China related multilateral agreements. The regional Comprehensive Economic Partnership (RCEP) announced last November is the world’s largest free trade agreement, covering approximately a third of the world’s population and economy. The China-EU Comprehensive Agreement on Investment (CAI) signed last December will reportedly grant the EU enhanced market access in China. These two agreements might have a deep impact on Canada-Asia trade and investment relations as well. Top business experts from Canada, the USA and China will discuss and debate on the best Canadian business strategies for China and Asia to promote Canadian business interests in the Area.
Saving Lives and Livelihoods: How will Moderna's vaccine change the course of Covid-19 Pandemic?
On March 23, 2021, China Business Studies Initiative (CBSI) hosted a fireside chat with Dr. Michael Rosenblatt, the Flagship Pioneering senior partner as part of the “Saving Lives and Livelihoods Speaker Series” that CBSI has been hosting since April of 2020, when the Covid-19 Pandemic was on the rise in the US and the rest of the world. During the conversation, Dr. Michael Rosenblatt, one of the world’s leading medical scientists who was involved in developing the now well-known Moderna Vaccine, shared many insights about the development process of creating the Covin vaccine, the innovative technology of mRNA used in the platform for this vaccine, and its efficacy. He also addressed many questions raised by the audience, including the resistance by certain population groups to the covid vaccine administration, vaccine equity and access challenges, vaccine diplomacy, and global cooperation for fighting against Covid-19 and any future pandemics.
The audience was able to hear first-hand on how the talent and outstanding work of prominent scientists and medical doctors led to the invention of the potential cure of the catastrophic virus in the modern conditions of the 21st Century. The discussion was moderated by Professor Tatoul Manasserian, who teaches International Business at USF, directs Research Center ALTERNATIVE in Armenia, and is a public policy expert, serving as a Member of Parliament in 2003-2007, as well as Professor Xiaohua Yang, the Director of China Business Studies Initiative, organizing the event.